ArticleScientific reports2025
Positioning accuracy and dosimetric evaluation of customized immobilization for FBCT guided VMAT in nasopharyngeal carcinoma.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
This study aims to expand and enhance traditional fixation techniques by comparing positioning errors and dosimetric variations in the target area and organs at risk (OARs) between conventional and customized immobilization strategies during radiotherapy for nasopharyngeal carcinoma (NPC). Additionally, we evaluate the benefits and necessity of continuous improvements in immobilization devices. Specify beam technique (VMAT) and sample size (n = 30; 15 per group): the traditional group (standard styrofoam, a thermoplastic mask (TM) with a universal oral stent (OS)) and the customized group (modified styrofoam, TM with a self-developed customized OS). Using diagnostic fan-beam computed tomography (FBCT) scans, we quantitatively assessed positioning errors in the overall target area as well as the oropharynx and neck regions with the two fixation methods. Additionally, we evaluated dosimetric changes in target areas and principal OARs during three stages of NPC radiotherapy (initial plan, week 4, and week 6) to ascertain dosimetric benefits. Compared to the traditional group, the customized group exhibited notably smaller positional errors throughout individual treatment sessions. The modifications implemented in the customized group had a more substantial impact and weight on reducing errors in the neck region. The customized group showed improved target dose coverage, such as the dose covering 95% of the target volume (D95), dose covering 98% of the target volume (D98) of primary planning gross tumor volume (PGTVp), the D95 and D98 of planning clinical target volume 1 (PCTV1), etc. Additionally, the customized group demonstrated a lower radiation dose to brainstem, temporomandibular joint, parotid-R, thyroid gland and other OARs. The customized immobilization strategy significantly enhances the reproducibility of patient positioning during NPC radiotherapy. A notable advantage of customized solutions may allow margin reduction and selective OAR sparing. Moreover, the "customized" clinical application should be utilized individually, taking into account multiple factors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.